Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 175-183

  Meijer, Hanneke J M ^a   Debats, Oscar A ^a   Kunze Busch, Martina ^a   Van Kollenburg, Peter ^a   Leer, Jan Willem ^a   Witjes, J Alfred ^a   Kaanders, Johannes H A M ^a   Barentsz, Jelle O ^a   Van Lin, Emile N J Th ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intensity modulated radiotherapy; Lymph node; Lymphotrophic superparamagnetic nanoparticles; Magnetic resonance imaging; Prostate cancer

Indexed keywords

CLINICAL STUDY; DOSE LEVELS; DOSE PRESCRIPTION; HIGH DOSE; INTENSITY-MODULATED RADIOTHERAPY; LYMPH NODE; ORGANS AT RISKS; PELVIC LYMPH NODES; PELVIC RADIOTHERAPY; PLANNING CT; PROSTATE CANCERS; RADIOTHERAPY PLANNING; SIMULTANEOUS INTEGRATED BOOSTS; SUPERPARAMAGNETIC NANOPARTICLES; TARGET VOLUMES;

COMPUTERIZED TOMOGRAPHY; DISEASES; IRRADIATION; MAGNETIC RESONANCE IMAGING; PHYSICAL THERAPY; RADIOTHERAPY; RESONANCE; SUPERPARAMAGNETISM;

BODY FLUIDS;

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; LYMPHOGRAPHY; MAGNETIC RESONANCE LYMPHOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIATION DOSE; TARGET ORGAN; TREATMENT PLANNING;

ADENOCARCINOMA; CONTRAST MEDIA; DEXTRANS; FEASIBILITY STUDIES; HUMANS; LYMPHATIC IRRADIATION; LYMPHOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; ORGANS AT RISK; PELVIS; PILOT PROJECTS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 83955162988     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.023     Document Type: Article

References (31)

1. C.A. Lawton, M. DeSilvio, and M. Roach III An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions Int J Radiat Oncol Biol Phys 69 2007 646 655
2. P. Pommier, S. Chabaud, and J.L. Lagrange Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01 J Clin Oncol 25 2007 5366 5373
3. S.A. Seaward, V. Weinberg, and P. Lewis Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer Int J Radiat Oncol Biol Phys 42 1998 1055 1062
4. C.E. Vargas, R. Galalae, and J. Demanes Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation Int J Radiat Oncol Biol Phys 63 2005 1474 1482
5. A.A. Aizer, J.B. Yu, and A.M. McKeon Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma Int J Radiat Oncol Biol Phys 75 2009 1344 1349
6. C.C. Pan, K.Y. Kim, and J.M. Taylor Influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy Int J Radiat Oncol Biol Phys 53 2002 1139 1145
7. C.A. Perez, J. Michalski, K.C. Brown, and M.A. Lockett Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 36 1996 573 584
8. T.A. Masterson, F.J. Bianco Jr., and A.J. Vickers The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer J Urol 175 2006 1320 1324
9. A. Briganti, J.R. Karnes, and L.F. Da Pozzo Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy Eur Urol 55 2009 261 270
10. M. Roach III, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 33 37
11. R. Martinez-Monge, P.S. Fernandes, N. Gupta, and R. Gahbauer Cross-sectional nodal atlas: A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning Radiology 211 1999 815 828
12. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383-377
13. U. Ganswindt, F. Paulsen, and S. Corvin Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition BMC Cancer 5 2005 91
14. G. Holl, R. Dorn, and H. Wengenmair Validation of sentinel lymph node dissection in prostate cancer: Experience in more than 2,000 patients Eur J Nucl Med Mol Imaging 36 2009 1377 1382
15. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
16. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
17. R.A. Heesakkers, A.M. Hovels, and G.J. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: A prospective multicohort study Lancet Oncol 9 2008 850 856
18. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499
19. H.C. Thoeny, M. Triantafyllou, and F.D. Birkhaeuser Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients Eur Urol 55 2009 761 769
20. O. Will, S. Purkayastha, and C. Chan Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: A meta-analysis Lancet Oncol 7 2006 52 60
21. Deserno WM, Debats OA, Rozema T, et al. Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancer. Int J Radiat Oncol Biol Phys (in press).
22. J.O. Barentsz, J.J. Futterer, and S. Takahashi Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients Eur J Radiol 63 2007 369 372
23. P. Scalliet, L. Renard, and B. Lengelé CTV for lymphatics in prostate adenocarcinoma: An anatomical description and clinical discussion V. Grégoire, P. Scalliet, K.K. Ang, Clinical target volumes in conformal and intensity modulated radiation therapy. A clinical guide to cancer treatment 2004 Springer-Verlag Berlin 145 156
24. A. Taylor, A.G. Rockall, and M.E. Powell An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition Clin Oncol (R Coll Radiol) 19 2007 542 550
25. M. Roach III, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
26. S.A. Joslyn, and B.R. Konety Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer Urology 68 2006 121 125
27. I. de Jong, J. Pruim, and P.H. Elsinga Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET J Nucl Med 44 2003 331 335
28. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429
29. J.B. Ashman, M.J. Zelefsky, and M.S. Hunt Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 63 2005 765 771
30. V. Fonteyne, W. de Gersem, and W. de Neve Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer Int J Radiat Oncol Biol Phys 75 2009 1013 1020
31. E.N. van Lin, J. Kristinsson, and M.E. Philippens Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy Int J Radiat Oncol Biol Phys 67 2007 799 811